{"id":"W2158890671","doi":"10.1158/1078-0432.ccr-07-1416","title":"A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies","year":2008,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Adverse effect; Toxicity; Internal medicine; Nausea; Pharmacokinetics; Cancer; Tumor necrosis factor alpha; Gastroenterology; Monoclonal antibody; Pharmacology; Oncology; Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006015984,0.0001189367,0.0002714189,0.0001119276,0.0001210765,0.000008180364,0.0002176041,0.0001147834,0.00003808135],"category_scores_gemma":[0.00009002058,0.00009543511,0.00005729406,0.0002695333,0.0001619965,0.000005808079,0.000141031,0.0002169814,0.000002802268],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002779814,"about_ca_system_score_gemma":0.0001775617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001667688,"about_ca_topic_score_gemma":0.0004491377,"domain_scores_codex":[0.9980425,0.0001983755,0.0004672479,0.0004742724,0.0004828653,0.0003348037],"domain_scores_gemma":[0.9989948,0.00002901272,0.00007936393,0.0003500418,0.0004103749,0.0001364546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0100852,0.0155593,0.4198489,0.00006609785,0.0001266079,0.00005176833,0.0009708165,0.0007521244,0.5167306,0.00004576214,0.0005149603,0.03524785],"study_design_scores_gemma":[0.01792916,0.03246414,0.9231985,0.00008084923,0.0000116218,0.000001044927,0.0003388107,0.00003706209,0.02395493,0.00004065686,0.001685016,0.0002582234],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987319,0.000124814,0.00007329484,0.00003747653,0.00006584298,0.0008664276,0.00002333977,0.000004380263,0.00007252228],"genre_scores_gemma":[0.9990089,0.000118207,0.0001946031,0.000032471,0.0001117802,0.00009949585,0.00007017712,0.0000209914,0.0003433736],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5033495,"threshold_uncertainty_score":0.3891731,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1057952036680042,"score_gpt":0.4970493390645815,"score_spread":0.3912541353965774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}